Clearside Biomedical, Inc.Clearside Biomedical, Inc.Clearside Biomedical, Inc.

Clearside Biomedical, Inc.

No trades
See on Supercharts
Market capitalization
‪94.15 M‬USD
−0.53USD
‪−32.49 M‬USD
‪8.23 M‬USD
‪63.00 M‬
Beta (1Y)
2.86

About Clearside Biomedical, Inc.

CEO
George M. Lasezkay
Headquarters
Alpharetta
Employees (FY)
30
Founded
2011
ISIN
US1850631045
FIGI
BBG002D4D4X3
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLSD is 1.32 USD — it has increased by 4.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Clearside Biomedical, Inc. stocks are traded under the ticker CLSD.
Clearside Biomedical, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CLSD stock is 12.10% volatile and has beta coefficient of 2.86. Check out the list of the most volatile stocks — is Clearside Biomedical, Inc. there?
One year price forecast for Clearside Biomedical, Inc. has a max estimate of 8.00 USD and a min estimate of 4.00 USD.
CLSD earnings for the last quarter are −0.15 USD whereas the estimation was −0.16 USD which accounts for 3.54% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Clearside Biomedical, Inc. earnings.
Clearside Biomedical, Inc. revenue for the last quarter amounts to ‪859.00 K‬ USD despite the estimated figure of ‪166.67 K‬ USD. In the next quarter revenue is expected to reach ‪4.43 M‬ USD.
Yes, you can track Clearside Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
CLSD stock has risen by 7.32% compared to the previous week, the month change is a 15.38% fall, over the last year Clearside Biomedical, Inc. has showed a 16.81% increase.
CLSD net income for the last quarter is ‪−4.83 M‬ USD, while the quarter before that showed ‪−9.27 M‬ USD of net income which accounts for 47.86% change. Track more Clearside Biomedical, Inc. financial stats to get the full picture.
Today Clearside Biomedical, Inc. has the market capitalization of ‪94.15 M‬, it has decreased by 7.86% over the last week.
No, CLSD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLSD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clearside Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CLSD reached its all-time high on Oct 10, 2016 with the price of 25.08 USD, and its all-time low was 0.56 USD and was reached on Aug 28, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 30.00 employees. See our rating of the largest employees — is Clearside Biomedical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Clearside Biomedical, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Clearside Biomedical, Inc. stock shows the sell signal. See more of Clearside Biomedical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Clearside Biomedical, Inc. future price: according to them, CLSD price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Read a more detailed Clearside Biomedical, Inc. forecast: see what analysts think of Clearside Biomedical, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Clearside Biomedical, Inc. EBITDA is ‪−24.78 M‬ USD, and current EBITDA margin is −301.20%. See more stats in Clearside Biomedical, Inc. financial statements.